126 related articles for article (PubMed ID: 10714493)
21. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives.
Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH
Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
Kanno O; Miyauchi M; Shibayama T; Ohya S; Kawamoto I
J Antibiot (Tokyo); 1999 Oct; 52(10):900-7. PubMed ID: 10604760
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antibacterial activity of new 1beta-methylcarbapenems having the potential for intramolecular nonbonded S...O interactions.
Nagao Y; Iimori H; Nam KH; Sano S; Shiro M
Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1660-1. PubMed ID: 11767095
[TBL] [Abstract][Full Text] [Related]
25. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships.
Aihara K; Kano Y; Shiokawa S; Sasaki T; Setsu F; Sambongi Y; Ishii M; Tohyama K; Ida T; Tamura A; Atsumi K; Iwamatsu K
Bioorg Med Chem; 2003 Aug; 11(16):3475-85. PubMed ID: 12878141
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Cho HW; Baek D; Cho JH
Eur J Med Chem; 2002 Sep; 37(9):743-54. PubMed ID: 12350291
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety.
Kang YK; Shin KJ; Yoo KH; Seo KJ; Hong CY; Lee CS; Park SY; Kim DJ; Park SW
Bioorg Med Chem Lett; 2000 Jan; 10(2):95-9. PubMed ID: 10673088
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety.
Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S
J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867
[TBL] [Abstract][Full Text] [Related]
29. Novel 1beta-methylcarbapenems with isoxazoloethenyl moieties containing carboxylic acid sodium salt.
Lee KS; Kang YK; Yoo KH; Kim DC; Shin KJ; Paik YS; Kim DJ
Bioorg Med Chem Lett; 2005 Jan; 15(1):231-4. PubMed ID: 15582445
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenem, against experimental murine systemic infections.
Shibata K; Nagano R; Hashizume T; Morishima H
J Antimicrob Chemother; 2000 Mar; 45(3):379-82. PubMed ID: 10702562
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of 1beta-methylcarbapenems having cyclic thiourea moieties and their related compounds.
Han T; Cho JH; Oh CH
Eur J Med Chem; 2006 Jul; 41(7):825-32. PubMed ID: 16737759
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial properties of BO-2727, a new carbapenem antibiotic.
Kato Y; Otsuki M; Nishino T
J Antimicrob Chemother; 1997 Aug; 40(2):195-203. PubMed ID: 9301984
[TBL] [Abstract][Full Text] [Related]
33. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity.
Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH
Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems.
Mastalerz H; Menard M; Ruediger E; Fung-Tomc J
J Med Chem; 1992 Mar; 35(5):953-8. PubMed ID: 1548685
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains.
Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I
J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antibacterial activity of 2-(isoxazolidinio-5-yl)carbapenem derivatives.
Nishi K; Imuta M; Kimura Y; Miwa H
J Antibiot (Tokyo); 1995 Dec; 48(12):1481-7. PubMed ID: 8557606
[TBL] [Abstract][Full Text] [Related]
37. Orally active carbapenem antibiotics I. Antibacterial and pharmacokinetic potential of 2-phenyl and 2-thienylcarbapenems.
Sunagawa M; Ueda Y; Okada S; Watanabe S; Hashizuka T; Hori S; Sasaki A; Eriguchi Y; Kanazawa K
J Antibiot (Tokyo); 2005 Dec; 58(12):787-803. PubMed ID: 16506696
[TBL] [Abstract][Full Text] [Related]
38. Convergent syntheses of oral THF 1beta-methylcarbapenems.
Bitha P; Li Z; Lin YI
J Antibiot (Tokyo); 1999 Jul; 52(7):643-8. PubMed ID: 10513844
[TBL] [Abstract][Full Text] [Related]
39. Carbapenems: the pinnacle of the beta-lactam antibiotics or room for improvement?
Edwards JR; Betts MJ
J Antimicrob Chemother; 2000 Jan; 45(1):1-4. PubMed ID: 10629005
[No Abstract] [Full Text] [Related]
40. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I
J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
